119 related articles for article (PubMed ID: 27987700)
1. Encapsulation of anticancer drug copper bis(8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release.
Weerasuriya DRK; Wijesinghe WPSL; Rajapakse RMG
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():206-213. PubMed ID: 27987700
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
[TBL] [Abstract][Full Text] [Related]
3. Lysozyme loading and release from Se doped hydroxyapatite nanoparticles.
Wang Y; Hao H; Zhang S
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():545-52. PubMed ID: 26838882
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous and hollow hydroxyapatite nanostructured particles as a drug delivery vehicle for the local release of ibuprofen.
Safi S; Karimzadeh F; Labbaf S
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():712-719. PubMed ID: 30184799
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic synthesis of hybrid hydroxyapatite nanoparticles using nanogel template for controlled release of bovine serum albumin.
Qin J; Zhong Z; Ma J
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():377-83. PubMed ID: 26952436
[TBL] [Abstract][Full Text] [Related]
6. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
[TBL] [Abstract][Full Text] [Related]
7. Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system.
Ye F; Guo H; Zhang H; He X
Acta Biomater; 2010 Jun; 6(6):2212-8. PubMed ID: 20004747
[TBL] [Abstract][Full Text] [Related]
8. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
[TBL] [Abstract][Full Text] [Related]
9. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
10. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous hydroxyapatite nanoparticles hydrothermally synthesized in aqueous solution with hexametaphosphate and tea polyphenols.
Zhou H; Yang M; Hou S; Deng L
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():439-445. PubMed ID: 27987729
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of simvastatin from hollow carbonated hydroxyapatite microspheres prepared by aspartic acid and sodium dodecyl sulfate.
Wang K; Wang Y; Zhao X; Li Y; Yang T; Zhang X; Wu X
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():565-571. PubMed ID: 28415500
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
14. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
15. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
16. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery.
Liu TY; Chen SY; Liu DM; Liou SC
J Control Release; 2005 Sep; 107(1):112-21. PubMed ID: 15982777
[TBL] [Abstract][Full Text] [Related]
17. Osteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery.
de Miguel L; Popa I; Noiray M; Caudron E; Arpinati L; Desmaele D; Cebrián-Torrejón G; Doménech-Carbó A; Ponchel G
Pharm Res; 2015 May; 32(5):1794-803. PubMed ID: 25504453
[TBL] [Abstract][Full Text] [Related]
18. Controlled Release of Chemotherapeutic Platinum-Bisphosphonate Complexes from Injectable Calcium Phosphate Cements.
Farbod K; Sariibrahimoglu K; Curci A; Hayrapetyan A; Hakvoort JN; van den Beucken JJ; Iafisco M; Margiotta N; Leeuwenburgh SC
Tissue Eng Part A; 2016 May; 22(9-10):788-800. PubMed ID: 27083055
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
